Homoeopathic Pharmacy in MD (Homoeopathy) — from the source substance to the regulated medicine

In BHMS, Homoeopathic Pharmacy is taught once, in the First Professional year, as HomUG-HP. It is a subject a student meets early and then carries quietly through every later year, in every prescription written and every medicine dispensed. The MD speciality in Homoeopathic Pharmacy returns to it at the level of the laboratory, the pharmacopoeia, the law and the industry. It is one of the seven Part II specialities of the NCH Competency Based Dynamic Curriculum for MD (Homoeopathy), from the 2024-25 batch; MGGAU examines it as “Hom. Pharmacy”.

The course runs three years under the 2024 Post-Graduate Regulations — Part I, about eighteen months, as a Junior Resident, and Part II as a Senior Resident. The speciality’s curriculum document lists its modules by topic code, and this orientation follows them. It is a compact syllabus in outline — seventeen speciality modules, several of them stated in a single line — and where the source is brief, this page is brief too.

**Part I, Paper 1 — Fundamentals of Homoeopathic Pharmacy.** Six modules.

– **Philosophy and development.** The basis on which homoeopathic pharmacy developed; the principles of pharmaceutics across the different schools of medicine and how they relate; and the concept of potentisation and its development, with homoeopathic pharmacy during and after Hahnemann’s time.
– **The pharmacopoeia.** The preparation of homoeopathic medicines according to the guidelines of homoeopathic pharmacopoeias.
– **Pharmaconomy.** Routes of administration, in general and in homoeopathy, and the principles of pharmacokinetics.
– **Knowledge of the drug substance.** Pharmacognosy and pharmacology for identifying drugs from their different sources and collecting and preserving them; phytochemistry and phytoconstituents; the toxicological dose and action of homoeopathic drugs; and, in the curriculum’s words, the scientific basis of the mode of action of homoeopathic medicines through the concept of nanotechnology.
– **Drug proving.** Hahnemannian proving, and the Homoeopathic Pathogenetic Trial.
– **Pharmaceutics.** The preparation of potentised medicines and mother preparations, their preservation, formulation and dispensing, and the safety rules of a manufacturing unit.

**Part I, Paper 2 — the clinical bridge.** Five modules on the fundamentals of clinical medicine in relation to pharmacy: evidence-based practice, a basic clinical approach built through clinical cases and bedside clinic, the cardinal manifestations of disease through their pathophysiology with the Hahnemannian and miasmatic classifications of symptoms, nutrition, and the interpretation of laboratory and radiological investigations. It keeps the speciality rooted in clinical medicine.

**Part I, Paper 3** is the Research Methodology and Biostatistics paper common to all seven specialities — and in a speciality that ends with a module on research, it is well placed.

**Part II, Paper 1 — the medicine made right.** Four modules.

– **Prescription writing and dispensing** — writing a legal prescription and avoiding errors in it; the methods and precautions of dispensing.
– **Laboratory methods** — the standard techniques for standardising homoeopathic medicines.
– **Drug laws and legislation** related to homoeopathic pharmacy.
– **Standardisation** — the goal of a good-quality homoeopathic product, and the quality-control tests that establish a substance is pure.

**Part II, Paper 2 — the wider field.** Seven modules.

– **Pharmacognosy** — the study of organised and unorganised drugs, and of animal sources, to establish their genuineness.
– **The Pharmacopoeia Commission for Indian Medicine & Homoeopathy** — including the functioning of the Central Drug Testing-cum-Appellate Laboratory, its activities, and the standards of homoeopathic drugs it has made.
– **Experimental pharmacology** — the ethical requirements for drug studies on animals, and the pharmacological action of homoeopathic drugs.
– **Pharmacovigilance** — the concept of the adverse drug reaction, and of vigilance over it.
– **Industrial management** — the principles of managing the homoeopathic pharmaceutical industry.
– **Hospital pharmacy** — its working, for good clinical practice.
– **Advancements and research** — the scope of research in homoeopathic pharmacy, and, in the curriculum’s phrase, the effectiveness of homoeopathic medicines in different life forms.

The source gives most of these modules a single content line each. Our sheet transcribes those lines and no more, so the detail of what each one teaches — which laws, which tests, which pharmacopoeial standards — is not yet on this platform’s record. We say so plainly rather than fill the space.

**Who this speciality forms.** The curriculum describes a scholar who understands the homoeopathic medicine as a made thing, with a chain of responsibility behind it: a substance correctly identified, a preparation made according to the pharmacopoeia, a product tested for quality, a prescription written legally, a dispensing done safely, and a watch kept afterwards for adverse reactions. Its reach runs from the hospital pharmacy to the laboratory, the regulator and the industry.

**What this room will hold.** Study notes following the CBDC modules: the development of potentisation, the pharmacopoeial preparation of medicines, pharmaconomy and pharmacokinetics, drug proving and the pathogenetic trial, standardisation and quality control, and orientations to the Pharmacopoeia Commission and the Central Drug Testing-cum-Appellate Laboratory. Pieces on drug law will be written from the legislation itself, cited, once it is on our record. Everything here carries the MD tag and the Homoeopathic Pharmacy category, so it also stands on the Homoeopathic Pharmacy topic in Homoeopathy Knowledge.